Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Flow cytometry analysis of IL-6 on PHA-M stimulated THP-1 cells with or without LPS treatment. Cells were fixed with 4% formaldehyde for 30 min on ince and permeabilized with IC permeabilization buffer (Product #PB001). After incubation with blocking buffer (Product # 37525) for 30 min on ice, cells were then stained with anti-IL-6 mouse monoclonal antibody (Product # M620) at 1:100 dilution with IC permeabilization buffer for 30 min on ice. After washing with ice-cold IC permeabilization buffer for 3 times, the cells were stained with DyLight 488 goat anti-mouse secondary antibody (Product # 35502) for 30 min on ice. A representative 10,000 cells were acquired for each sample.
|Tested species reactivity||Human|
|Published species reactivity||Pig, Human, Mouse|
|Host / Isotype||Mouse / IgG1, kappa|
|Immunogen||Recombinant human IL-6.|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Flow Cytometry (Flow)||1:100|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
M620 was successfully to detect IL-6 in Flow application.
M620 targets IL-6 in ELISA, and Western blot applications and shows reactivity with human samples.
The M620 immunogen is recombinant human IL-6.
M620 detects IL-6 which has a predicted molecular weight of approximately 22 kDa.
The M620 IL6 antibody (clone 5IL6) has successfully been paired as the coating antibody in a sandwich ELISA with detection antibody M621B (biotinylated conjugate of clone 7IL6). Typical dilutions for sandwich ELISA include 1 µg/ml for coating and 0.125 - 0.25 µg/ml for detection.
Antibody M620 (clone 5IL6) and biotinylated antibody M621B (clone 7IL6) have successfully been used in combination with recombinant IL6 protein SIL6 in ELISA applications.
This gene encodes a cytokine that functions in inflammation and the maturation of B cells. The protein is primarily produced at sites of acute and chronic inflammation, where it is secreted into the serum and induces a transcriptional inflammatory response through interleukin 6 receptor, alpha. The functioning of this gene is implicated in a wide variety of inflammation-associated disease states, including suspectibility to diabetes mellitus and systemic juvenile rheumatoid arthritis.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6.
M620 was used in ELISA to develop a validated assay to measure complexed and non-complexed IL-6.
|Chaturvedi S,Siegel D,Wagner CL,Park J,van de Velde H,Vermeulen J,Fung MC,Reddy M,Hall B,Sasser K||British journal of clinical pharmacology (80:687)||2015|
Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
M620 was used in ELISA to investigate the role of p38 kinase in rheumatoid arthritis synovial membranes
|Page TH,Brown A,Timms EM,Foxwell BM,Ray KP||Arthritis and rheumatism (62:3221)||2010|
Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
M620 was used in ELISA to develop a multiplex Luminex assay to measure pig cytokines for vaccine development
|Lawson S,Lunney J,Zuckermann F,Osorio F,Nelson E,Welbon C,Clement T,Fang Y,Wong S,Kulas K,Christopher-Hennings J||Vaccine (28:5356)||2010|
A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.
M620 was used in ELISA to investigate the role of Lactobacillus polysaccharide peptidoglycan complex in chronic intestinal inflammatory disorders
|Matsumoto S,Hara T,Nagaoka M,Mike A,Mitsuyama K,Sako T,Yamamoto M,Kado S,Takada T||Immunology (128:e170)||2009|
Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism.
M620 was used in ELISA to study the role of human mast cells in the recruitment of natural killer cells
|Burke SM,Issekutz TB,Mohan K,Lee PW,Shmulevitz M,Marshall JS||Blood (111:5467)||2008|
IgE modulates neutrophil survival in asthma: role of mitochondrial pathway.
M620 was used in ELISA to study the role of mitochondrial pathway in neutrophil survival
|Saffar AS,Alphonse MP,Shan L,Hayglass KT,Simons FE,Gounni AS||Journal of immunology (Baltimore, Md. : 1950) (178:2535)||2007|
Protein microarray platform for the multiplex analysis of biomarkers in human sera.
M620 was used in ELISA to develop a protein microarray platform for the multiplex analysis of biomarkers in human sera
|Urbanowska T,Mangialaio S,Zickler C,Cheevapruk S,Hasler P,Regenass S,Legay F||Journal of immunological methods (316:1)||2006|
Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells.
M620 was used in ELISA to study the effect of Lactobacillus casei strain Shirota on the production of interleukin 6 in LPS-stimulated murine large intestinal lamina propria mononuclear cells
|Matsumoto S,Hara T,Hori T,Mitsuyama K,Nagaoka M,Tomiyasu N,Suzuki A,Sata M||Clinical and experimental immunology (140:417)||2005|
Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
M620 was used in ELISA to study the effect of etanercept treatment on proinflammatory cytokine-secreting peripheral blood mononuclear cells in rheumatoid arthritic patients
|Schotte H,Schlüter B,Willeke P,Mickholz E,Schorat MA,Domschke W,Gaubitz M||Rheumatology (Oxford, England) (43:960)||2004|
Serum cytokine levels, cigarette smoking and airway responsiveness among pregnant women.
M620 was used in ELISA to investigate the relationship between serum cytokine levels, cigarette smoking and airway responsiveness among pregnant women
|Tsunoda M,Litonjua AA,Kuniak MP,Weiss ST,Satoh T,Guevarra L,Tollerud DJ||International archives of allergy and immunology (130:158)||2003|
Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.
M620 was used in ELISA to investigate the role of mast cells/basophils in dengue pathogenesis
|King CA,Marshall JS,Alshurafa H,Anderson R||Journal of virology (74:7146)||2000|
Regulation of interleukin-12 by complement receptor 3 signaling.
M620 was used in ELISA to assess the interferon-alpha production in peripheral blood mononuclear cell
|Marth T,Kelsall BL||The Journal of experimental medicine (185:1987)||1997|
Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy.
M620 was used in ELISA to investigate the changes of interleukin 6 level in patients with cancer immunotherapy
|May LT,Patel K,García D,Ndubuisi MI,Ferrone S,Mittelman A,Mackiewicz A,Sehgal PB||Blood (84:1887)||1994|
A nonsteroidal glucocorticoid receptor antagonist.
M620 was used in immunocytochemistry to characterize a potent nonsteroidal antagonist against glucocorticoid receptor
|Miner JN,Tyree C,Hu J,Berger E,Marschke K,Nakane M,Coghlan MJ,Clemm D,Lane B,Rosen J||Molecular endocrinology (Baltimore, Md.) (17:117)||2003|
B-cell differentiation factor; B-cell stimulatory factor 2; BSF-2; CDF; CTL differentiation factor; Hybridoma growth factor; IFN-beta-2; IL-6; Interferon beta-2; interleukin BSF-2; interleukin HP-1; Interleukin-6
BSF-2; BSF2; CDF; HGF; HSF; IFN-beta-2; IFNB2; IL-6; IL6